natgillin/translations-raw huggingface dataset:
Medlemsstaterne tillader ikke, at investeringsselskaber udfører aggregerede kundeordrer eller transaktioner for egen regning, medmindre følgende betingelser er opfyldt:
Member States shall not permit investment firms to carry out a client order or a transaction for own account in aggregation with another client order unless the following conditions are met:
Det skal være usandsynligt, at en aggregering af ordrerne og transaktionerne overordnet vil være til ulempe for nogen enkelt kunde, hvis ordre indgår heri.
it must be unlikely that the aggregation of orders and transactions will work overall to the disadvantage of any client whose order is to be aggregated;
Hver enkelt af disse kunder, hvis ordre vil blive samlet, skal oplyses om, at denne aggregering kan være til ulempe for dem for så vidt angår en bestemt ordre.
it must be disclosed to each client whose order is to be aggregated that the effect of aggregation may work to its disadvantage in relation to a particular order;
Selskabet skal fastlægge og reelt følge en ordreallokeringspolitik, der giver mulighed for en tilstrækkelig rimelig allokering af aggregerede ordrer og transaktioner, herunder hvordan ordrernes omfang og pris har betydning for allokeringer og behandlingen af delvis udførte ordrer.
an order allocation policy must be established and effectively implemented, providing in sufficiently precise terms for the fair allocation of aggregated orders and transactions, including how the volume and price of orders determines allocations and the treatment of partial executions.
Medlemsstaterne sikrer, at når et investeringsselskab aggregerer en ordre med en eller flere andre kundeordrer, og den aggregerede ordre kun delvis udføres, allokerer selskabet de dermed forbundne handler i overensstemmelse med sin ordreallokeringspolitik.
Member States shall ensure that where an investment firm aggregates an order with one or more other client orders and the aggregated order is partially executed, it allocates the related trades in accordance with its order allocation policy.
Aggregering og allokering af transaktioner for egen regning
Aggregation and allocation of transactions for own account
Medlemsstaterne sikrer, at investeringsselskaber, der har aggregeret transaktioner for egen regning med en eller flere kundeordrer, ikke fordeler de dermed forbundne handler, således at det er til ugunst for kunden.
Member States shall ensure that investment firms which have aggregated transactions for own account with one or more client orders do not allocate the related trades in a way that is detrimental to a client.
Medlemsstaterne sikrer, at når et investeringsselskab aggregerer en kundeordre med en transaktion for egen regning, og den samlede ordre kun delvis udføres, tildeles de dermed forbundne handler kunden frem for selskabet.
Member States shall require that, where an investment firm aggregates a client order with a transaction for own account and the aggregated order is partially executed, it allocates the related trades to the client in priority to the firm.
Hvis et investeringsselskab imidlertid er i stand til at fremlægge tilstrækkelige beviser for, at det uden denne kombination ikke ville have kunnet udføre ordren på lige så fordelagtige vilkår, om overhovedet, kan det fordele transaktionen forholdsmæssigt for egen regning i overensstemmelse med den ordreallokeringspolitik, der er omhandlet i artikel 48, stk. 1, litra c).
However, if the firm is able to demonstrate on reasonable grounds that without the combination it would not have been able to carry out the order on such advantageous terms, or at all, it may allocate the transaction for own account proportionally, in accordance with its order allocation policy referred to in Article 48(1)(c).
Medlemsstaterne kræver, at investeringsselskaber som en del af ordreallokeringspolitikken, jf. artikel 48, stk. 1, litra c), fastlægger procedurer, der har til formål at forhindre omallokering af transaktioner for egen regning, der udføres sammen med kundeordrer, på en sådan måde, at det er til skade for kundens interesser.
Member States shall require investment firms, as part of the order allocation policy referred to in Article 48(1)(c), to put in place procedures designed to prevent the reallocation, in a way that is detrimental to the client, of transactions for own account which are executed in combination with client orders.
Godkendte modparter
Eligible counterparties
(Artikel 24, stk. 3, i direktiv 2004/39/EF)
(Article 24(3) of Directive 2004/39/EC)
Medlemsstaterne kan godkende et selskab som en godkendt modpart, hvis selskabet falder ind under en kundekategori, der skal betragtes som professionelle kunder i overensstemmelse med punkt 1, 2 og 3 i afsnit I i bilag II til direktiv 2004/39/EF, hvilket udelukker alle kategorier, der udtrykkeligt er nævnt i artikel 24, stk. 2, i nævnte direktiv.
Member States may recognise an undertaking as an eligible counterparty if that undertaking falls within a category of clients who are to be considered professional clients in accordance with paragraphs 1, 2 and 3 of Section I of Annex II to Directive 2004/39/EC, excluding any category which is explicitly mentioned in Article 24(2) of that Directive.
Medlemsstaterne kan på anmodning også godkende andre selskaber som modparter, som falder ind under en kundekategori, der skal betragtes som professionelle kunder i overensstemmelse med afsnit II i bilag II til direktiv 2004/39/EF.
On request, Member States may also recognise as eligible counterparties undertakings which fall within a category of clients who are to be considered professional clients in accordance with Section II of Annex II to Directive 2004/39/EC.
I sådanne tilfælde godkendes selskabet imidlertid kun som modpart for så vidt angår tjenesteydelser eller transaktioner, i forbindelse med hvilke det kan behandles som en professionel kunde.
In such cases, however, the undertaking concerned shall be recognised as an eligible counterparty only in respect of the services or transactions for which it could be treated as a professional client.
Hvis en godkendt modpart i medfør af artikel 24, stk. 2, andet afsnit, i direktiv 2004/39/EF anmoder om at blive behandlet som en kunde, hvis forretningsaktiviteter med et investeringsselskab er omfattet af artikel 19, 21 og 22 i nævnte direktiv, men ikke udtrykkeligt anmoder om at blive behandlet som detailkunde, og investeringsselskabet efterkommer anmodningen, behandler selskabet den godkendte modpart som professionel kunde.
Where, pursuant to the second subparagraph of Article 24(2) of Directive 2004/39/EC, an eligible counterparty requests treatment as a client whose business with an investment firm is subject to Articles 19, 21 and 22 of that Directive, but does not expressly request treatment as a retail client, and the investment firm agrees to that request, the firm shall treat that eligible counterparty as a professional client.
Hvis den godkendte modpart imidlertid udtrykkeligt anmoder om at blive behandlet som detailkunde, finder bestemmelserne for så vidt angår anmodninger om at blive behandlet som ikke-professionel kunde anvendelse, jf. andet, tredje og fjerde afsnit i afsnit I i bilag II til direktiv 2004/39/EF.
However, where that eligible counterparty expressly requests treatment as a retail client, the provisions in respect of requests of non-professional treatment specified in the second, third and fourth sub-paragraphs of Section I of Annex II to Directive 2004/39/EC shall apply.
Registrering
Record-keeping
(Artikel 13, stk. 6, i direktiv 2004/39/EF)
(Article 13(6) of Directive 2004/39(EC)
Opbevaring af fortegnelser
Retention of records
Medlemsstaterne kræver, at investeringsselskaber opbevarer alle de fortegnelser, som kræves i henhold til direktiv 2004/39/EF og gennemførelsesforanstaltningerne hertil, i mindst fem år.
Member States shall require investment firms to retain all the records required under Directive 2004/39/EC and its implementing measures for a period of at least five years.
Derudover skal fortegnelser, hvori investeringsselskabets og kundens respektive rettigheder og forpligtelser er fastsat i henhold til en aftale om levering af tjenesteydelser, eller hvori betingelserne for selskabets levering af tjenesteydelser til kunden er fastsat, opbevares i mindst hele det tidsrum, kunderelationen består.
Additionally, records which set out the respective rights and obligations of the investment firm and the client under an agreement to provide services, or the terms on which the firm provides services to the client, shall be retained for at least the duration of the relationship with the client.
De kompetente myndigheder kan dog i undtagelsestilfælde kræve, at investeringsselskaber opbevarer en eller alle disse fortegnelser i et længere tidsrum, end hvad instrumentets eller transaktionens art kan berettige, hvis det er nødvendigt, for at myndigheden kan udøve sine tilsynsfunktioner i medfør af direktiv 2004/39/EF.
However, competent authorities may, in exceptional circumstances, require investment firms to retain any or all of those records for such longer period as is justified by the nature of the instrument or transaction, if that is necessary to enable the authority to exercise its supervisory functions under Directive 2004/39/EC.
Når et investeringsselskabs tilladelse ophører, kan medlemsstaterne eller de kompetente myndigheder kræve, at selskabet opbevarer fortegnelserne i den resterende del af det femårige tidsrum, der kræves i første afsnit.
Following the termination of the authorisation of an investment firm, Member States or competent authorities may require the firm to retain records for the outstanding term of the five year period required under the first subparagraph.
Fortegnelserne skal opbevares på et medium, der tillader lagring af oplysningerne, således at den kompetente myndighed fremover kan henvise til dem, og i en sådan form og på en sådan måde, at følgende betingelser er opfyldt:
The records shall be retained in a medium that allows the storage of information in a way accessible for future reference by the competent authority, and in such a form and manner that the following conditions are met:
Den kompetente myndighed skal let kunne få adgang til dem og kunne rekonstruere enhver vigtig fase af behandlingen af hver transaktion.
the competent authority must be able to access them readily and to reconstitute each key stage of the processing of each transaction;
Det skal være muligt let at fastslå eventuelle rettelser eller andre ændringer og fortegnelsernes indhold forud for sådanne eventuelle rettelser eller andre ændringer.
it must be possible for any corrections or other amendments, and the contents of the records prior to such corrections or amendments, to be easily ascertained;
Det skal ikke være muligt at manipulere eller på anden vis at ændre fortegnelserne.
it must not be possible for the records otherwise to be manipulated or altered.
Hver medlemsstats kompetente myndighed udarbejder og fører en liste over de fortegnelser, investeringsselskaber som et minimum skal føre i henhold til direktiv 2004/39/EF og gennemførelsesbestemmelserne hertil.
The competent authority of each Member State shall draw up and maintain a list of the minimum records investment firms are required to keep under Directive 2004/39/EC and its implementing measures.
Registreringsforpligtelserne i medfør af direktiv 2004/39/EF og dette direktiv påvirker ikke medlemsstaternes ret til at pålægge investeringsselskaber forpligtelser for så vidt angår registrering af telefonsamtaler eller elektroniske meddelelser vedrørende kundeordrer.
Record-keeping obligations under Directive 2004/39/EC and in this Directive are without prejudice to the right of Member States to impose obligations on investment firms relating to the recording of telephone conversations or electronic communications involving client orders.
Inden den 31. december 2009 rapporterer Kommissionen i lyset af drøftelser med Det Europæiske Værdipapirtilsynsudvalg til Europa-Parlamentet og Rådet om, hvorvidt bestemmelserne i stk. 4 fortsat er hensigtsmæssige.
Before 31 December 2009 the Commission shall, in the light of discussions with the Committee of European Securities Regulators, report to the European Parliament and the Council on the continued appropriateness of the provisions of paragraph 4.
Definitioner med henblik på direktiv 2004/39/EF
Defined terms for the purposes of Directive 2004/39/EC
(Artikel 4, stk. 1, nr. 4), i direktiv 2004/39/EF)
(Article 4(1)(4) of Directive 2004/39/EC)
For så vidt angår definitionen af »investeringsrådgivning« i artikel 4, stk. 1, nr. 4), i direktiv 2004/39/EF forstås ved personlig anbefaling en anbefaling, der gives til en person i dennes egenskab af investor eller potentiel investor eller dennes egenskab af agent for en investor eller potentiel investor.
For the purposes of the definition of ‘investment advice’ in Article 4(1)(4) of Directive 2004/39/EC, a personal recommendation is a recommendation that is made to a person in his capacity as an investor or potential investor, or in his capacity as an agent for an investor or potential investor.
Anbefalingen skal fremsættes som passende for den pågældende person eller tage udgangspunkt i personens egne omstændigheder og skal udgøre en anbefaling til at tage et af følgende skridt:
That recommendation must be presented as suitable for that person, or must be based on a consideration of the circumstances of that person, and must constitute a recommendation to take one of the following sets of steps:
at købe, sælge, tegne, udveksle, indløse, beholde eller garantere et bestemt finansielt instrument
to buy, sell, subscribe for, exchange, redeem, hold or underwrite a particular financial instrument;
at udøve eller undlade at udøve en rettighed, der skyldes et bestemt finansielt instrument, til at købe, sælge, tegne, udveksle eller indløse et finansielt instrument.
to exercise or not to exercise any right conferred by a particular financial instrument to buy, sell, subscribe for, exchange, or redeem a financial instrument.
En anbefaling anses ikke for en personlig anbefaling, hvis den udelukkende udsendes via distributionskanaler eller til offentligheden.
A recommendation is not a personal recommendation if it is issued exclusively through distribution channels or to the public.
Medlemsstaterne anvender disse bestemmelser fra den 1. november 2007.
Member States shall apply those provisions from 1 November 2007.
Udfærdiget i Bruxelles, den 10. august 2006.
Done at Brussels, 10 August 2006.
Ændret ved direktiv 2006/31/EF (EUT L 114 af 27.4.2006, s. 60).
Directive as amended by Directive 2006/31/EC (OJ L 114, 27.4.2006, p. 60).
EFT L 193 af 18.7.1983, s. 1.
OJ No L 193, 18.7.1983, p. 1.
EUT L 177 af 30.6.2006. s. 1.
OJ L 177, 30.6.2006, p. 1.
Kommissionens direktiv 2006/74/EF
Commission Directive 2006/74/EC
af 21. august 2006
of 21 August 2006
om ændring af Rådets direktiv 91/414/EØF for at optage dichlorprop-P, metconazol, pyrimethanil og triclopyr som aktive stoffer
amending Council Directive 91/414/EEC to include dichlorprop-P, metconazole, pyrimethanil and triclopyr as active substances
Listen omfatter dichlorprop-P, metconazol, pyrimethanil og triclopyr.
That list includes dichlorprop-P, metconazole, pyrimethanil and triclopyr.
For dichlorprop-P var den rapporterende medlemsstat Danmark, og alle relevante oplysninger blev forelagt den 5. november 2003.
For dichlorprop-P the rapporteur Member State was Denmark and all relevant information was submitted on 5 November 2003.
For metconazol var den rapporterende medlemsstat Belgien, og alle relevante oplysninger blev forelagt den 27. januar 2004.
For metconazole the rapporteur Member State was Belgium and all relevant information was submitted on 27 January 2004.
For pyrimethanil var den rapporterende medlemsstat Østrig, og alle relevante oplysninger blev forelagt den 15. april 2004.
For pyrimethanil the rapporteur Member State was Austria and all relevant information was submitted on 15 April 2004.
For triclopyr var den rapporterende medlemsstat Irland, og alle relevante oplysninger blev forelagt den 21. november 2003.
For triclopyr the rapporteur Member State was Ireland and all relevant information was submitted on 21 November 2003.
Medlemsstaterne og EFSA har underkastet vurderingsrapporterne et peer review, og de blev forelagt for Kommissionen hhv. den 14. december 2005 i form af EFSA's videnskabelige rapport om triclopyr og den 13. januar 2006 i form af EFSA's videnskabelige rapporter om dichlorprop-P, metconazol og pyrimethanil [4].
The assessment reports have been peer reviewed by the Member States and the EFSA and presented to the Commission on 14 December 2005 for triclopyr and on 13 January 2006 for dichlorprop-P, metconazole and pyrimethanil in the format of the EFSA Scientific Reports [4].
Disse rapporter er blevet behandlet af medlemsstaterne og Kommissionen i Den Stående Komité for Fødevarekæden og Dyresundhed, og behandlingen blev afsluttet den 23. maj 2006 med Kommissionens reviderede vurderingsrapporter om dichlorprop-P, metconazol, pyrimethanil og triclopyr.
These reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 23 May 2006 in the format of the Commission review reports for dichlorprop-P, metconazole, pyrimethanil and triclopyr.
Det fremgår af diverse undersøgelser, at plantebeskyttelsesmidler, der indeholder dichlorprop-P, metconazol, pyrimethanil og triclopyr, kan forventes generelt at opfylde kravene i artikel 5, stk. 1, litra a) og b), i direktiv 91/414/EØF, især med hensyn til de anvendelsesformål, der er undersøgt og udførligt beskrevet i Kommissionens reviderede vurderingsrapporter.
It has appeared from the various examinations made that plant protection products containing dichlorprop-P, metconazole, pyrimethanil and triclopyr may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports.
Dichlorprop-P, metconazol, pyrimethanil og triclopyr bør derfor optages i bilag I for at sikre, at godkendelse af plantebeskyttelsesmidler, der indeholder disse aktive stoffer, i alle medlemsstater finder sted i overensstemmelse med direktiv 91/414/EØF.
It is therefore appropriate to include these active substances in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive.
Uanset denne konklusion bør der indhentes yderligere oplysninger om visse spørgsmål vedrørende dichlorprop-P, pyrimethanil og triclopyr.
Without prejudice to that conclusion, it is appropriate to obtain further information on certain specific points concerning dichlorprop-P, pyrimethanil and triclopyr.
Erfaringerne fra tidligere optagelser i bilag I til direktiv 91/414/EØF af aktive stoffer, som er vurderet inden for rammerne af forordning (EØF) nr. 3600/92 [5], har vist, at der kan opstå vanskeligheder med fortolkningen af de pligter, som indehavere af eksisterende godkendelser har med hensyn til adgang til data.
The experience gained from previous inclusions in Annex I to Directive 91/414/EEC of active substances assessed in the framework of Commission Regulation (EEC) No 3600/92 [5] has shown that difficulties can arise in interpreting the duties of holders of existing authorisations in relation to access to data.
Medlemsstaterne vedtager og offentliggør senest den 30. november 2007 de love og administrative bestemmelser, der er nødvendige for at efterkomme dette direktiv.
Member States shall adopt and publish by 30 November 2007 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
De anvender disse bestemmelser fra den 1. december 2007.
They shall apply those provisions from 1 December 2007.
Om nødvendigt ændrer eller tilbagekalder medlemsstaterne i henhold til direktiv 91/414/EØF senest den 30. november 2007 eksisterende godkendelser af plantebeskyttelsesmidler, der indeholder dichlorprop-P, metconazol, pyrimethanil og triclopyr som aktive stoffer.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing dichlorprop-P, metconazole, pyrimethanil and triclopyr as active substances by 30 November 2007.
Inden da skal medlemsstaterne navnlig kontrollere, at betingelserne i bilag I til direktiv 91/414/EØF vedrørende dichlorprop-P, metconazol, pyrimethanil og triclopyr er overholdt, dog ikke betingelserne i del B vedrørende disse aktive stoffer, og at indehaveren af godkendelsen er i besiddelse af eller har adgang til et dossier, der opfylder kravene i bilag II til direktivet, jf. betingelserne i direktivets artikel 13.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to dichlorprop-P, metconazole, pyrimethanil and triclopyr are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Uanset stk. 1 revurderer medlemsstaterne for hvert godkendt plantebeskyttelsesmiddel, der indeholder dichlorprop-P, metconazol, pyrimethanil og triclopyr, enten som eneste aktive stof eller som ét af flere aktive stoffer, som alle er optaget i bilag I til direktiv 91/414/EØF pr. 31. maj 2007, midlet i overensstemmelse med de ensartede principper i bilag VI til direktiv 91/414/EØF på grundlag af et dossier, der opfylder kravene i bilag III til nævnte direktiv, idet der samtidig tages højde for del B i bilag I til direktivet vedrørende hhv. dichlorprop-P, metconazol, pyrimethanil og triclopyr.
By way of derogation from paragraph 1, for each authorised plant protection product containing dichlorprop-P, metconazole, pyrimethanil and triclopyr as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 May 2007 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning dichlorprop-P, metconazole, pyrimethanil and triclopyr respectively.
hvis det drejer sig om et middel, der indeholder dichlorprop-P, metconazol, pyrimethanil og triclopyr som eneste aktive stof, om nødvendigt ændre godkendelsen eller trække den tilbage senest den 31. maj 2011, eller
in the case of a product containing dichlorprop-P, metconazole, pyrimethanil and triclopyr as the only active substance, where necessary, amend or withdraw the authorisation by 31 May 2011 at the latest; or
hvis det drejer sig om et middel, der indeholder dichlorprop-P, metconazol, pyrimethanil eller triclopyr som ét af flere aktive stoffer, om nødvendigt ændre godkendelsen eller trække den tilbage senest den 31. maj 2011 eller senest den dato, der er fastsat for en sådan ændring eller tilbagetrækning i det eller de pågældende direktiver, hvorved det eller de pågældende stoffer blev optaget i bilag I til direktiv 91/414/EØF, alt efter hvilket der er det seneste tidspunkt.
in the case of a product containing dichlorprop-P, metconazole, pyrimethanil and triclopyr as one of several active substances, where necessary, amend or withdraw the authorisation by 31 May 2011 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
Dette direktiv træder i kraft den 1. juni 2007.
This Directive shall enter into force on 1 June 2007.
Udfærdiget i Bruxelles, den 21. august 2006.
Done at Brussels, 21 August 2006.